Last $4.21 USD
Change Today +0.43 / 11.38%
Volume 11.9M
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jack L. Wyszomierski

Director and Chairman of Audit Committee, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 4 different organizations across 5 different industries.

See Board Relationships
58$345,172

Background*

Mr. Jack L. Wyszomierski served as an Executive Vice President and Chief Financial Officer of VWR Funding Inc., and VWR International Inc., from June 2004 to June 30, 2009. Mr. Wyszomierski served as an Executive Vice President and Chief Financial Officer of Schering Plough Corp. from 1996 to November 17, 2003. He served as Executive Vice President and Chief Financial Officer of Schering-Plough Corporation from 1996 to November 17, 2003. From 1982 to 2003, he held positions ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

2004-Present
Director and Chairman of Audit Committee
2010-Present
Director, Member of Nominations & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
2010-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
2012-Present
Director and Chairman of Audit Committee

Education*

MS
Carnegie Mellon University
BS
Carnegie Mellon University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$59,000
Total Calculated Compensation$345,172
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $4.21 USD +0.43

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.